WHO expects to review Chinese vaccines on April 26 - official
WHO expects to review Chinese vaccines on April 26 - official
GENEVA, April 9 (Reuters) - China&aposs COVID-19 vaccines, made by Sinopharm and Sinovac SVA.O , are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.
A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.
他说,第二次会议计划在5月3日的那一周举行,届时将根据需要审查第二次会议。
WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine&aposs safety and efficacy.
世卫组织紧急使用清单是被Covax疫苗共享机构购买的先决条件,也是向监管机构较弱的国家发出的关于疫苗&APOSS安全性和有效性的信号。
译文内容由第三方软件翻译。